{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-003175","form_type":"8-K","ticker":"MGTX","cik":"0001735438","company_name":"MeiraGTx Holdings plc","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.340643+00:00","generated_at":"2026-06-04T19:53:56.487528+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MeiraGTx reports FY2023 net loss of $84M, down 35% YoY; Janssen deal yields $50M milestone","bullets":["Net loss $84.0M ($1.49/share) vs $129.6M ($2.87) in 2022; license revenue $14.0M.","Janssen asset purchase for bota-vec (XLRP) up to $415M; $65M upfront + $50M milestone in Feb 2024.","Sanofi invested $30M at $7.50/share; ROFN for riboswitch in CNS, I&I, metabolic disease.","FDA aligns Phase 2 AQUAx2 for xerostomia as pivotal; AAV-AIPL1 shows meaningful responses in 8 LCA4 children.","Cash $129.6M at Dec 31, 2023; expects funding into Q1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-003175","json":"https://secwatch.observer/filing/0001558370-24-003175.json","markdown":"https://secwatch.observer/filing/0001558370-24-003175.md","text":"https://secwatch.observer/filing/0001558370-24-003175.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735438/000155837024003175/0001558370-24-003175-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735438/000155837024003175/mgtx-20240314x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T19:53:56.487528+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d70b0f02d350f66c556c5b9fe9f1930092403f4","claim":"MeiraGTx Holdings plc reported financial results for the fourth quarter and full-year ended December 31, 2023.","evidence_excerpt":"On March 14, 2024, MeiraGTx Holdings plc (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1735438/000155837024003175/0001558370-24-003175-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full-year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}